HRP920889B1 - Tablet and granulate containing mesna as active agent - Google Patents

Tablet and granulate containing mesna as active agent

Info

Publication number
HRP920889B1
HRP920889B1 HRP-1226/91A HRP920889A HRP920889B1 HR P920889 B1 HRP920889 B1 HR P920889B1 HR P920889 A HRP920889 A HR P920889A HR P920889 B1 HRP920889 B1 HR P920889B1
Authority
HR
Croatia
Prior art keywords
weight
parts
tablet
mesna
active agent
Prior art date
Application number
HRP-1226/91A
Other languages
English (en)
Inventor
Dieter Sauerbier
Juergen Engel
Eckhard Milsmann
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from YU122691A external-priority patent/YU48665B/sh
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of HRP920889A2 publication Critical patent/HRP920889A2/xx
Publication of HRP920889B1 publication Critical patent/HRP920889B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glanulating (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP-1226/91A 1990-07-16 1992-10-02 Tablet and granulate containing mesna as active agent HRP920889B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
YU122691A YU48665B (sh) 1990-07-16 1991-07-12 Postupak za proizvodnju stabilnih tableta i granulata, koji kao aktivnu materiju sadrže natrijum-2-merkaptoetansulfonat (mesna)
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (2)

Publication Number Publication Date
HRP920889A2 HRP920889A2 (en) 1996-04-30
HRP920889B1 true HRP920889B1 (en) 1998-02-28

Family

ID=25895027

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1226/91A HRP920889B1 (en) 1990-07-16 1992-10-02 Tablet and granulate containing mesna as active agent

Country Status (31)

Country Link
US (1) US5262169A (es)
EP (1) EP0468245B1 (es)
JP (1) JP3068894B2 (es)
KR (1) KR100189666B1 (es)
CN (1) CN1072484C (es)
AT (1) ATE104548T1 (es)
AU (1) AU638586B2 (es)
BG (2) BG60851B1 (es)
CA (1) CA2047027C (es)
DE (2) DE59101431D1 (es)
DK (1) DK0468245T3 (es)
EG (1) EG20019A (es)
ES (1) ES2063412T3 (es)
FI (1) FI97949C (es)
HK (1) HK129894A (es)
HR (1) HRP920889B1 (es)
HU (1) HU206630B (es)
IE (1) IE65373B1 (es)
IL (1) IL98836A (es)
LT (1) LT3527B (es)
LV (1) LV10040B (es)
MC (1) MC2273A1 (es)
MX (1) MX174407B (es)
NO (1) NO178362C (es)
NZ (1) NZ238941A (es)
PT (1) PT98325B (es)
RO (1) RO113713B1 (es)
RU (1) RU2070040C1 (es)
SG (1) SG142394G (es)
SI (1) SI9111226A (es)
ZA (1) ZA915515B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0560092B1 (de) * 1992-03-11 1997-12-03 ASTA Medica Aktiengesellschaft Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
ATE65402T1 (de) * 1988-03-19 1991-08-15 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.

Also Published As

Publication number Publication date
IE912463A1 (en) 1992-01-29
AU8044591A (en) 1992-01-16
CN1058337A (zh) 1992-02-05
JP3068894B2 (ja) 2000-07-24
DK0468245T3 (da) 1994-05-16
FI97949B (fi) 1996-12-13
IL98836A0 (en) 1992-07-15
ES2063412T3 (es) 1995-01-01
RO113713B1 (ro) 1998-10-30
FI913409A0 (fi) 1991-07-15
CA2047027A1 (en) 1992-01-17
LV10040A (lv) 1994-05-10
KR920002154A (ko) 1992-02-28
LV10040B (en) 1995-06-20
CN1072484C (zh) 2001-10-10
RU2070040C1 (ru) 1996-12-10
BG60901B1 (bg) 1996-06-28
ATE104548T1 (de) 1994-05-15
DE59101431D1 (de) 1994-05-26
PT98325A (pt) 1992-05-29
SI9111226A (en) 1995-04-30
KR100189666B1 (ko) 1999-06-01
NO912771L (no) 1992-01-17
IL98836A (en) 1994-11-28
SG142394G (en) 1995-01-13
NZ238941A (en) 1993-03-26
HRP920889A2 (en) 1996-04-30
IE65373B1 (en) 1995-10-18
DE4122167A1 (de) 1992-01-23
NO178362B (no) 1995-12-04
MX174407B (es) 1994-05-13
HU912374D0 (en) 1991-12-30
HU206630B (en) 1992-12-28
BG60851B1 (bg) 1996-05-31
CA2047027C (en) 1996-09-17
MC2273A1 (fr) 1993-06-23
FI913409A (fi) 1992-01-17
PT98325B (pt) 1999-01-29
NO178362C (no) 1996-03-13
JPH04230319A (ja) 1992-08-19
LTIP920A (en) 1995-03-27
EG20019A (en) 1997-01-30
HUT59317A (en) 1992-05-28
ZA915515B (en) 1992-04-29
HK129894A (en) 1994-12-02
LT3527B (en) 1995-11-27
AU638586B2 (en) 1993-07-01
EP0468245A1 (de) 1992-01-29
NO912771D0 (no) 1991-07-15
EP0468245B1 (de) 1994-04-20
US5262169A (en) 1993-11-16
FI97949C (fi) 1997-03-25

Similar Documents

Publication Publication Date Title
ES430431A1 (es) Varistor de oxido metalico.
EG20019A (en) A tablet and granulate containing mesna as active substance
DE2963990D1 (en) Analgesic tablet and process for its preparation
CZ10095A3 (en) Tablet with enhanced biological access of clodronic acid active component, packaging of such tablets and the use of the active component for the preparation of the tablets and process of producing such tablets
GB2021409A (en) Pharmaceutical composition
GB2295966B (en) Direct compression tablets
YU122691A (sh) Tablete i granulat koji kao aktivnu materiju sadrže natrijum-2-merkapto-etansulfonat
KR920000316A (ko) 젬피브로질 제제
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
USD241155S (en)
JPS55160715A (en) Tablet having improved disintegrating property
USD215763S (en) Wallace k
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5297602A (en) Rack unit
IT1241925B (it) Compressa a rapida solubilita', per prodotti dietetici
TH1402S (th) ขาปรับระดับสำหรับตู้เย็น
Rappe Environmental impact of brominated flame retardants.
KR930007451A (ko) 우리딘을 유효성분으로 함유하는 관절염 치료제
JPS53122679A (en) Process for preparing forming tablets
GB2213062A (en) Pharmaceutical preparation having oestrogen action
JPS52121195A (en) Container
ZA949652B (en) Dithiocarbonimide derivative fungicidal/insecticidal/acaricidal agent containing said derivative as active ingredient intermediate for use in production of said derivative and process for producing said derivative from said intermediate
JPS5380611A (en) Safety frame structure for agricultural tractor or the like

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040630

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20050713